b.kaufmann
Submits third-party assay reports on material purchased directly. Based in Aarhus.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.27%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041816 | GHRP-2 | ASY | ASY-{CAT}-2426 | Janoshik | 2026-Q2 | 99.64 | 6.45 | 90.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042244 | BPC-157 | TFC | TFC-2604-A9366 | Nordanalyt | 2026-Q2 | 99.55 | 5.64 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021230 | 5-Amino-1MQ | PPG | PPG-2510-E7748 | Janoshik | 2025-Q4 | 99.42 | 3.43 | 104.1 | Buyer-sourced | 0 | FAIL |
| AX-2025-020389 | Semaglutide | MKM | MKM-2507-D4229 | Nordanalyt | 2025-Q4 | 98.86 | 4.91 | 92.7 | Buyer-sourced | 0 | PASS |
| AX-2025-019225 | Enclomiphene citrate | SinoPep | SNP-2503-J5227 | Janoshik | 2025-Q3 | 99.03 | 4.96 | — | Laboratory-retained | 0 | FAIL |
| AX-2025-020979 | PT-141 (Bremelanotide) | WXT | WXT-2507-R4042 | Janoshik | 2025-Q3 | 99.11 | 4.85 | 93.2 | Buyer-sourced | 0 | PASS |
| AX-2025-018946 | Retatrutide | ASY | ASY-{CAT}-1860 | Janoshik | 2025-Q3 | 97.85 | 5.80 | 100.0 | Laboratory-retained | 0 | PASS |
| AX-2024-004967 | Semax | MKM | MKM-2407-Y4392 | Nordanalyt | 2024-Q3 | 99.68 | 10.99 | — | Buyer-sourced | 0 | PASS |